Statement Of Comprehensive Income [Abstract]

Innate Pharma - Filing #2811003

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)	— EUR	7 570 EUR	— EUR	7 570 EUR	— EUR	— EUR	— EUR	— EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR
Other comprehensive income [abstract]
Other comprehensive income	—	670,000 EUR	—	—	—	—	—	—	—	—	362,000 EUR	—	—	—	—	—
Comprehensive income	— EUR	6 900 EUR	324,000 EUR	7 570 EUR	994,000 EUR	— EUR	— EUR	— EUR	— EUR	362,000 EUR	57 741 EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR